In new research published in the open-access, peer-reviewed scientific journal PLoS ONE, Dr Patrice Dubreuil and colleagues characterise the pharmacological profile of masitinib (AB1010), a novel tyrosine kinase inhibitor ...
Sep 30, 2009 in Cancer
(AP) -- The Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs.
Jun 03, 2009 in Cancer
- 1 2